{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:10:10Z","timestamp":1788948610394,"version":"build-2803163510"},"reference-count":18,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1134\/s1607672926600156","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:56:24Z","timestamp":1783958184000},"page":"194-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design of Nucleoside Prodrugs for the Inhibition of Tick-Borne Encephalitis Virus Reproduction"],"prefix":"10.1134","volume":"528","author":[{"given":"A. A.","family":"Zenchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Kaleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. I.","family":"Uvarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"Khvatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. I.","family":"Osolodkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. E.","family":"Oslovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"7839_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","volume":"5","author":"T.C. Pierson","year":"2020","unstructured":"Pierson, T.C. and Diamond, M.S., The continued threat of emerging flaviviruses, Nat. Microbiol., 2020, vol. 5, pp. 796\u2013812. https:\/\/doi.org\/10.1038\/s41564-020-0714-0","journal-title":"Nat. Microbiol"},{"key":"7839_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","volume":"164","author":"D. Ruzek","year":"2019","unstructured":"Ruzek, D., \u017dupanc, T.A., Borde, J., et al., Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines, Antiviral Res., 2019, vol. 164, pp. 23\u201351. https:\/\/doi.org\/10.1016\/j.antiviral.2019.01.014","journal-title":"Antiviral Res."},{"key":"7839_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1292\/jvms.18-0373","volume":"81","author":"K. Yoshii","year":"2019","unstructured":"Yoshii, K., Epidemiology and pathological mechanisms of tick-borne encephalitis, J. Vet. Med. Sci., 2019, vol. 81, no. 3, pp. 343\u2013347. https:\/\/doi.org\/10.1292\/jvms.18-0373","journal-title":"J. Vet. Med. Sci."},{"key":"7839_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/cmr.00102-15","volume":"29","author":"E. De Clercq","year":"2016","unstructured":"De Clercq, E. and Li, G., Approved antiviral drugs over the past 50 years, Clin. Microbiol. Rev., 2016, vol. 29, pp. 695\u2013747. https:\/\/doi.org\/10.1128\/cmr.00102-15","journal-title":"Clin. Microbiol. Rev"},{"key":"7839_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","volume":"154","author":"K.L. Seley-Radtke","year":"2018","unstructured":"Seley-Radtke, K.L. and Yates, M.K., The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold, Antiviral Res., 2018, vol. 154, pp. 66\u201386. https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.004","journal-title":"Antiviral Res."},{"key":"7839_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.antiviral.2018.11.016","volume":"162","author":"M.K. Yates","year":"2019","unstructured":"Yates, M.K. and Seley-Radtke, K.L., The evolution of antiviral nucleoside analogues: a review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold, Antiviral Res. 2019, vol. 162, pp. 5\u201321. https:\/\/doi.org\/10.1016\/j.antiviral.2018.11.016","journal-title":"Antiviral Res."},{"key":"7839_CR7","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1021\/jm060217p","volume":"49","author":"P. Ertl","year":"2006","unstructured":"Ertl, P., Jelfs, S., Muhlbacher, J., et al., Quest for the rings. in silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds, J. Med. Chem. 2006, vol. 49, pp. 4568\u20134573. https:\/\/doi.org\/10.1021\/jm060217p","journal-title":"J. Med. Chem."},{"key":"7839_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2174\/1389200033489253","volume":"4","author":"K. Beaumont","year":"2003","unstructured":"Beaumont, K., Webster. R., Gardner, I., and Dack, K., Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist, Curr. Drug Metab., 2003, vol. 4, no. 6, pp.\u00a0461\u2013485. https:\/\/doi.org\/10.2174\/1389200033489253","journal-title":"Curr. Drug Metab"},{"key":"7839_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0065-7743(04)39023-8","volume":"39","author":"R.L. Mackman","year":"2004","unstructured":"Mackman, R.L. and Cihlar, T., Prodrug strategies in the design of nucleoside and nucleotide antiviral therapeutics, Annu. Rep. Med. Chem., 2004, vol. 39, pp.\u00a0305\u2013321. https:\/\/doi.org\/10.1016\/S0065-7743(04)39023-8","journal-title":"Annu. Rep. Med. Chem."},{"key":"7839_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ejmech.2016.10.061","volume":"127","author":"V. Abet","year":"2017","unstructured":"Abet, V., Filace, F., Recio, J., et al., Prodrug approach: An overview of recent cases, Eur. J. Med. Chem., 2017, vol. 127, pp. 810\u2013827. https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.061","journal-title":"Eur. J. Med. Chem."},{"key":"7839_CR11","doi-asserted-by":"publisher","unstructured":"Cruz, G., Acosta, J., Del Arco, J., et al., Enzyme-mediated synthesis of Molnupiravir: paving the way for the application of biocatalysis in pharmaceutical industry, ChemCatChem, 2022, vol. 14, no. 13, e202200140. https:\/\/doi.org\/10.1002\/cctc.202200140","DOI":"10.1002\/cctc.202200140"},{"key":"7839_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejmech.2016.01.036","volume":"111","author":"M.S. Drenichev","year":"2016","unstructured":"Drenichev, M.S., Oslovsky, V.E., Sun, L., et al., Modification of the length and structure of the linker of N\n               6-benzyladenosine modulates its selective antiviral activity against enterovirus 71, Eur. J. Med. Chem., 2016, vol.\u00a0111, pp. 84\u201394. https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.036","journal-title":"Eur. J. Med. Chem."},{"key":"7839_CR13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.bmcl.2017.01.040","volume":"27","author":"A.A. Orlov","year":"2017","unstructured":"Orlov, A.A., Drenichev, M.S., Oslovsky, V.E., et al., New tools in nucleoside toolbox of tick-borne encephalitis virus reproduction inhibitors, Bioorg. Med. Chem. Lett., 2017, vol. 27, no. 5, pp. 1267\u20131273. https:\/\/doi.org\/10.1016\/j.bmcl.2017.01.040","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"7839_CR14","doi-asserted-by":"publisher","unstructured":"Zenchenko, A.A., Oslovsky, V.E., Varizhuk, I.V., et al., Cytotoxicity reduction by O-nicotinoylation of antiviral 6-benzylaminopurine ribonucleosides, Toxicol. In Vitro, 2022, vol. 82, 105355. https:\/\/doi.org\/10.1016\/j.tiv.2022.105355","DOI":"10.1016\/j.tiv.2022.105355"},{"key":"7839_CR15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1081\/SCC-200051693","volume":"35","author":"A.K. Prasad","year":"2005","unstructured":"Prasad, A.K., Kumar, V., Maity, J., et al., Benzoyl cyanide: a mild and efficient reagent for benzoylation of nucleosides, Synth. Commun., 2005, vol. 35, no. 7, pp.\u00a0935\u2013945. https:\/\/doi.org\/10.1081\/SCC-200051693","journal-title":"Synth. Commun."},{"key":"7839_CR16","doi-asserted-by":"publisher","unstructured":"Sedenkova, K.N., Uvarova, V.I., Nazarova, A.A., et al., Tetrahydroquinazoline N-oxide derivatives inhibit reproduction of tick-borne and mosquito-borne flaviviruses, Arch. Pharm., 2023, vol. 356, no. 7, 2300027. https:\/\/doi.org\/10.1002\/ardp.202300027","DOI":"10.1002\/ardp.202300027"},{"key":"7839_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"L.J. Reed","year":"1938","unstructured":"Reed, L.J. and Muench, H., A simple method of estimating fifty per cent endpoints, Am. J. Epidemiol. 1938, vol. 27, pp. 493\u2013497. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a118408","journal-title":"Am. J. Epidemiol"},{"key":"7839_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.bioorg.2019.03.028","volume":"87","author":"D.A. Vasilenko","year":"2019","unstructured":"Vasilenko, D.A., Dueva, E.V., Kozlovskaya, L.I., et al., Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantine, Bioorg. Chem., 2019, vol. 87, pp. 629\u2013637. https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.028","journal-title":"Bioorg. Chem."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672926600156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672926600156","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672926600156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:52:51Z","timestamp":1788947571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672926600156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7839"],"URL":"https:\/\/doi.org\/10.1134\/s1607672926600156","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work does not contain any studies involving human and animal subjects.","order":1,"name":"Ethics","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","label":"CONFLICT OF INTEREST","group":{"name":"EthicsHeading","label":"Ethics"}}]}}